Vertex Pharmaceuticals Stock Surges on FDA Approval of Non-Opioid Painkiller

Vertex Pharmaceuticals (NASDAQ: VRTX) stock price surged on Thursday following the U.S. Food and Drug Administration's (FDA) approval of the company's non-opioid painkiller, Journavx. The drug, designed to treat moderate-to-severe acute pain, is a significant milestone in the ongoing effort to combat the opioid epidemic in the United States and beyond.